Liu, J., Feng, M., Xu, N., Zhang, Z., Shi, J., Li, X., Li, W., Zhou, H., Qin, Y., Zhou, C. (2026). Phase I study of LB1410, a bivalent TIM-3/PD-1 bispecific antibody, in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2639